Résumé
En rééducation, la prise en compte des patients, quelle que soit la pathologie, y compris ceux atteints de pathologie du système nerveux périphérique, est centrée sur la définition de projets de soins et de vie personnalisés.
This is a preview of subscription content, log in via an institution to check access.
Preview
Unable to display preview. Download preview PDF.
Références
Hamonet C, Pilato M, Kissous M (1994) Obésité et Handicap. Évaluation avec un nouvel instrument: le handicapomètre. Comparaison avec l’index de Barthel. Ann Réadapt Méd Phys 37: 395–402
Bohannon RW (1987) Measurement, nature and implications of skeletal muscle strength in patients with neurological disorders. Clinical Biomechanics 10:283–92
Cook JD (1987) Strengh evaluation in neuromuscular disease. Neurol Clin 5(1): 101–24
Merlini L, Granata C (1990) Rehabilitation for children with muscle disease. Current Opinion in Neurology and Neurosurgery 3: 748–41
Dyck PJ, Pineda A, Swanson C et al. (1982b) The Mayoclinic experience with plasma exchange in chronic inflammatory-demyelinating polyneuropathy (CIDP). Prog Clin Biol Res 106:197–204
Merkies IS, Lauria G (2006) 131 st ENMC international workshop: selection of outcome measures for peripheral neuropathy clinical trials 10–12 december 2004, Naarden, The Netherlands. Neuromuscul Disord 16(2): 149–56
Merkies ISJ, Schmitz PIM, Van der Meché FGA et al. (2002) Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies. J Neurol Neurosurg Psychiatry 72: 596–601
VanNes SI, Vanhoutte EK, VanDoorn PA et al. (2011) Rasch-built Overall Disability scale (R-ODS) for immune-mediated peripheral neuropathies. Neurology 76: 337–45
Graham RC, Hughes RAC (2006) A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale. J Neurol Neurosurg Psychiatry 77:973–6
Molenaar DSM, De Haan R, Vermeulen M (1995) Impairment, disability, or handicap in peripheral neuropathy: analysis of the use of outcome measures in clinical trials in patients with peripheral neuropathies. J Neurol Neurosurg Psychiatry 59:165–9
Merkies ISJ, Hughes RAC, Donofrio P et al. (2010) Understanding the consequences of chronic inflammatory demyelinating plyradiculoneuropathy from impairments to activity and participation restrictions and reduced quality of life: the ICE study. J Peripher Nerv Syst 15:208–15
Merkies IS, Schmitz PI, van der Meché FG et al. Inflammatory Neuropathy Cause and Treatment (INCAT) Group (2003) Connecting impairment, disability, and handicap in immune mediated polyneuropathies? J Neurol Neurosurg Psychiatry 74(1): 99–104
Lennon SM, Koblar S, Hughes RAC et al. (1993) Reasons for persistent disability in Guillain-Barré syndrome. Clin Rehabil 7:1–8
Bethoux F, Calmels P (2003) Guide des outils de mesure et d’évaluation en médecine de réadaptation. In: Frison-Roche (ed), Paris, p. 403
Magy L (2006) Quoi de neuf depuis 10 ans dans l’évaluation des neuropathies périphériques? Rev Neurol 162:1279–83
Rapin A, Tambosco L, Bombart V et al. (2011) Actualités de l’évaluation clinique dans les maladies neuromusculaires lentement progressives à l’âge adulte. Journal de réadaptation médicale 31:115–8
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2012 Springer-Verlag Paris
About this chapter
Cite this chapter
Salle, JY., Magy, L., Hamonet-Torny, J., Daviet, JC. (2012). Nouvelles échelles d’évaluation clinique des atteintes du système nerveux périphérique. In: Plexus brachial Actualités et perspectives. Springer, Paris. https://doi.org/10.1007/978-2-8178-0334-0_3
Download citation
DOI: https://doi.org/10.1007/978-2-8178-0334-0_3
Publisher Name: Springer, Paris
Print ISBN: 978-2-8178-0333-3
Online ISBN: 978-2-8178-0334-0
eBook Packages: MedicineMedicine (R0)